GE sells BioPharma business to CEO's former company for $21.4 billion | CNN Business
General Electric — Wikipédia
GE to Sell Its Biotech Business to Danaher for $21 Billion - WSJ
GE To Sell Its BioPharma Unit For $21.4 Billion To Danaher | GE News
Danaher absorbing GE's bioprocess biz in $21.4bn deal - BioProcess InternationalBioProcess International
GE to sell BioPharma business to Danaher for $21.4B | Fox Business
GE sells BioPharma business to CEO's former company for $21.4 billion | CNN Business
GE To Sell Biopharma Business For $21.4bn – Independent Newspaper Nigeria
GE Sells Coveted BioPharma Unit to Pay Down $21 Billion in Crippling Debt
GE sells biopharma unit for US$21 billion | CTV News
GE sells BioPharma business to CEO's former company
GE agrees to sell BioPharma unit to Danaher for US$21.4 billion
GE sells BioPharma business to CEO's former company for $21.4 billion | CNN Business
GE to sell life sciences business for $21.4 billion | Crain's Chicago Business
GE Deal With Danaher Shows Culp Is All About the Balance Sheet - Bloomberg
GE chief Larry Culp sells biopharma business for $21 billion
GE to Sell Its Biotech Business to Danaher for $21 Billion - WSJ
Baxter sells Biopharma Solutions unit for $4.25B | BioWorld
GE To Sell Its BioPharma Unit For $21.4 Billion To Danaher | GE News
GE Healthcare float sunk in favour of Danaher deal | Evaluate
GE Sells Coveted $21 Billion BioPharma to Pay Down Crippling Debt Load
GE sells its biopharma business to Danaher for $21.4 billion
GE: The Biopharma Deal Is Nearing Completion
GE Healthcare leaves GE, looks to 'next chapter'
GE sells biopharma drug business to Danaher for $21.4 billion
